Please login to the form below

irritable bowel syndrome

This page shows the latest irritable bowel syndrome news and features for those working in and with pharma, biotech and healthcare.

Ardelyx gets second kidney disease trial win for tenapanor

verdict on the use of the drug in irritable bowel syndrome.

Latest news

China approves Ironwood Pharma’s IBS treatment

Coincides with AZ's Mark Mallon taking over as CEO. Ironwood Pharmaceuticals’ irritable bowel syndrome treatment Linzess has gained approval in China, opening up a market of up to 14m adults ... Approval by China’s NMPA for adults with irritable
Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

pain associated with irritable bowel syndrome (IBSs).
NHS could save £7bn with greater diagnostics use

The report specifically evaluated the savings of three existing IVD tests - covering suspected heart attacks, pre-eclampsia in pregnancy and diagnosing irritable bowel syndrome (IBS) - if widely used. ... Lastly, IVDs for common bowel condition IBS could
Mallinckrodt pays $1.2bn for Sucampo Pharma

Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic constipation as well as constipation linked to irritable bowel syndrome and chronic opioid
NICE backs Allergan's IBS therapy Truberzi

NICE has recommended routine NHS funding for Allergan's Truberzi, which is the first drug for irritable bowel syndrome with diarrhoea (IBS-D) to pass through its review process.

More from news
Approximately 0 fully matching, plus 49 partially matching documents found.

Latest Intelligence

Erectile dysfunction, constipation, vaginal dryness and other laughing matters

An Irritable Bowel Syndrome campaign tackled the challenge of IBS not being taken seriously by actually using humour. ... This campaign showed doctors suffering from Irritable Disbelief Syndrome (IDS) - a brave move but exactly the perception shift
Taking a lean and careful approach

His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation. ... ulcerative colitis, type 1 diabetes and inflammatory bowel disease.
Can biosimilars live up to the hype?

She is convinced that biosimilars are essential in treating patients with chronic conditions such as rheumatoid arthritis, irritable bowel syndrome and psoriasis, because they provide the same uplift in quality of
Oral biologics delivery still elusive

years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome. ... Among these are Avaxia Biologics, which
Pharma deals during April 2014

proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is ... delta opioid receptor antagonist for

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

Ironwood appoints Edward Owens to board

irritable bowel syndrome and constipation.
Ironwood promotes Dr Mark Currie

Linaclotide was approved as a treatment for irritable bowel syndrome last year by regulators in Europe, where the drug is marketed as Constella by Almirall.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Diagnosing MS: are we getting it right?

MS symptoms can be hard to pin down. I’ve heard bladder issues being attributed to “women’s problems”, bowel issues to irritable bowel syndrome (IBS), and fatigue to stress and
World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer

Symptoms of ovarian cancer. The symptoms of ovarian cancer are quite similar to those for less serious conditions such as irritable bowel syndrome or pre-menstrual syndrome [3]. ... Other symptoms include persistent indigestion or nausea, a change in
Irritable Bowel Syndrome (IBS) patient insights

Irritable Bowel Syndrome: Patient–Provider Interaction and Patient Education. J Clin Med. 2018; 7(1):3. -----. ... Irritable bowel syndrome in adults: diagnosis and management. NICE Clinical Guideline 61; 2017.
IGNIFI

Irritable Bowel Syndrome (IBS) patient insights.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

B2B media account director: Competitive salary

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Entry Level Account Executive – Healthcare Advertising – London...: Salary TBC

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

AM / Senior Account Manager – Healthcare PR - London / Remote: Highly Competitive Salary, Bonus &Benefits

FREELANCE Associate Director - Healthcare PR - Remote or London: Superb Day Rate &Benefits

PMHub

Add my company

Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password:

Please login to the form below

irritable bowel syndrome

COVID-19 Updates and Daily News

Featured jobs

Quick links